Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $12,500 | 1 | 87.5% |
| Food and Beverage | $921.90 | 43 | 6.5% |
| Travel and Lodging | $817.97 | 3 | 5.7% |
| Education | $44.00 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $12,557 | 3 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $1,244 | 25 | $0 (2019) |
| Astellas Pharma US Inc | $403.82 | 17 | $0 (2024) |
| Allergan Inc. | $78.43 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $114.04 | 4 | Astellas Pharma US Inc ($114.04) |
| 2020 | $23.76 | 1 | Astellas Pharma US Inc ($23.76) |
| 2019 | $242.94 | 12 | Astellas Pharma US Inc ($95.84) |
| 2018 | $13,626 | 16 | PFIZER INC. ($12,500) |
| 2017 | $276.99 | 15 | Astellas Pharma US Inc ($127.54) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/14/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: Infectious Diseases | ||||||
| 09/16/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: Infectious Diseases | ||||||
| 08/12/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $29.00 | General |
| Category: Infectious Diseases | ||||||
| 04/15/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $32.62 | General |
| Category: Infectious Diseases | ||||||
| 02/25/2020 | Astellas Pharma US Inc | AMBISOME (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: HOSPITAL AND TRANSPLANT | ||||||
| 11/18/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/15/2019 | Astellas Pharma US Inc | MYCAMINE (Drug) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/28/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/13/2019 | Astellas Pharma US Inc | AMBISOME (Drug), MYCAMINE | Food and Beverage | In-kind items and services | $23.56 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 05/20/2019 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/14/2019 | Astellas Pharma US Inc | AMBISOME (Drug), MYCAMINE | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 04/15/2019 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/12/2019 | Allergan Inc. | TEFLARO (Drug) | Education | In-kind items and services | $44.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/05/2019 | Astellas Pharma US Inc | AMBISOME (Drug), MYCAMINE | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 03/18/2019 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 02/25/2019 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/14/2019 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/23/2018 | Astellas Pharma US Inc | AMBISOME (Drug), MYCAMINE | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/12/2018 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/05/2018 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $12,500.00 | General |
| 10/22/2018 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/20/2018 | Merck Sharp & Dohme Corporation | NOXAFIL (Drug) | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/26/2018 | Merck Sharp & Dohme Corporation | SIVEXTRO (Drug) | Food and Beverage | In-kind items and services | $49.99 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/26/2018 | Merck Sharp & Dohme Corporation | SIVEXTRO (Drug) | Travel and Lodging | Cash or cash equivalent | $48.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/26/2018 | Merck Sharp & Dohme Corporation | SIVEXTRO (Drug) | Food and Beverage | In-kind items and services | $45.79 | General |
| Category: INFECTIOUS DISEASE | ||||||
About Dr. Sheldon Kaplan, MD
Dr. Sheldon Kaplan, MD is a Pediatric Infectious Diseases healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1982784245.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sheldon Kaplan, MD has received a total of $14,284 in payments from pharmaceutical and medical device companies, with $114.04 received in 2024. These payments were reported across 48 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($12,500).
Practice Information
- Specialty Pediatric Infectious Diseases
- Location Houston, TX
- Active Since 10/17/2006
- Last Updated 07/08/2007
- Taxonomy Code 2080P0208X
- Entity Type Individual
- NPI Number 1982784245
Products in Payments
- SIVEXTRO (Drug) $1,011
- NOXAFIL (Drug) $233.21
- Mycamine (Drug) $127.54
- AMBISOME (Drug) $117.89
- Cresemba (Drug) $114.04
- MYCAMINE (Drug) $44.35
- TEFLARO (Drug) $44.00
- AVYCAZ (Drug) $34.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Infectious Diseases Doctors in Houston
Flor De Maria Munoz, Md, MD
Pediatric Infectious Diseases — Payments: $203,352
Dr. Rene Amaya, Md, MD
Pediatric Infectious Diseases — Payments: $84,107
Carol Baker, Md, MD
Pediatric Infectious Diseases — Payments: $42,942
Dr. Micah Bhatti, M.d., Phd, M.D., PHD
Pediatric Infectious Diseases — Payments: $30,056
Gloria Heresi, M.d, M.D
Pediatric Infectious Diseases — Payments: $23,670
Gail Demmler, Md, MD
Pediatric Infectious Diseases — Payments: $14,888